Remove Immunization Remove Labelling Remove Specialty Pharmacies
article thumbnail

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Drug Topics

By tailoring your pharmacy to meet the needs of customers across both prescription and over-the-counter (OTC) products, you can transform your store into a long-term community destination for total health and wellness. Private-label brands allow you to deliver the same quality as larger name brands, often at a lower cost. April 2025.

article thumbnail

Hair Loss Therapy Shows Potential for Regeneration in Phase 2 Trial

Drug Topics

After the randomized portion of the study, patients were eligible to enroll in an open-label extension study for 3 months to assess the long term safety of PP405. Patients applied the therapy or placebo once per day for 4 weeks and were followed for up to 12 weeks.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

of YA with obesity were prescribed OMs—predominantly GLP-1s approved for adults but used off label for younger people. Despite the high prevalence of obesity among children and YA, OM utilization remains low,” wrote authors of the abstract. 1 In the final year of the analysis (2024), just 1.5% of adolescents and 5.7%

article thumbnail

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Drug Topics

Image Credit: sonyakamoz - stock.adobe.com "We have been conditioned to equate weight loss with health, and weight loss-resistant individuals are often labeled as failures,” Anat Yaskolka Meir, PhD, postdoctoral research fellow in the department of epidemiology at Harvard Chan School, said in a news release.

article thumbnail

Mifepristone Reduces HbA1c in Patients With T2D, Hypercortisolism | ADA 2025

Drug Topics

The study also showed the therapy’s safety profile was consistent with its current label. 1 Data from the study were presented at the American Diabetes Association’s 85th Scientific Sessions, which were held June 20-23 in Chicago, Illinois. No new side effects or adverse events were identified during the trial.

article thumbnail

Results Find SGLT2 Inhibitors Associated With Erythrocytosis

Drug Topics

2 One of the risks of SGLT2is has been an increase in hematocrit levels, ranging from 2.3% in clinical trials, according to a case series published in Endocrine Abstracts.

article thumbnail

Procedure Shows Promise for Sustained Weight Loss After GLP-1 Therapy

Drug Topics

The study is an open-label cohort trial aimed at evaluating the safety, tolerability, and early efficacy of Revita for patients who lost at least 15% or more of their total body weight with a recently discontinued GLP-1.